Expansion of an atypical NK cell subset in mouse models of systemic lupus erythematosus

Journal of Immunology

Volumn 194, Issue 4, 2015, Pages 1503-1513

  Voynova, Elisaveta N ^a   Skinner, Jeffrey ^a   Bolland, Silvia ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; MESSENGER RNA; MICRORNA; MICRORNA 15; MICRORNA 150; MICRORNA 16; MICRORNA 181; MICRORNA 744; RAS PROTEIN; TOLL LIKE RECEPTOR 7; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL EXPANSION; CELL LINEAGE; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENE EXPRESSION; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TLR7 GENE; UPREGULATION; ADOPTIVE TRANSFER; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; DNA MICROARRAY; HISTOCOMPATIBILITY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY;

ADOPTIVE TRANSFER; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSPLANTATION CHIMERA;

EID: 84922569339     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402673     Document Type: Article

References (52)

1. Galli, S. J., N. Borregaard, and T. A. Wynn. 2011. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 12: 1035-1044.
2. Nagai, Y., K. P. Garrett, S. Ohta, U. Bahrun, T. Kouro, S. Akira, K. Takatsu, and P. W. Kincade. 2006. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24: 801-812.
3. Green, N. M., and A. Marshak-Rothstein. 2011. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin. Immunol. 23: 106-112.
4. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
5. Lau, C. M., C. Broughton, A. S. Tabor, S. Akira, R. A. Flavell, M. J. Mamula, S. R. Christensen, M. J. Shlomchik, G. A. Viglianti, I. R. Rifkin, and A. Marshak-Rothstein. 2005. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202: 1171-1177.
6. Pisitkun, P., J. A. Deane, M. J. Difilippantonio, T. Tarasenko, A. B. Satterthwaite, and S. Bolland. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312: 1669-1672.
7. + B cells to produce lupus auto-antibodies in vivo. Eur. J. Immunol. 25: 3412-3417.
8. -/- mice. J. Exp. Med. 195: 1167-1174.
9. 1 male mice, but not in C57BL/6 male mice. Eur. J. Immunol. 18: 911-915.
10. Deane, J. A., P. Pisitkun, R. S. Barrett, L. Feigenbaum, T. Town, J. M. Ward, R. A. Flavell, and S. Bolland. 2007. Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27: 801-810.
11. Walsh, E. R., P. Pisitkun, E. Voynova, J. A. Deane, B. L. Scott, R. R. Caspi, and S. Bolland. 2012. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proc. Natl. Acad. Sci. USA 109: 16276-16281.
12. Rowland, S. L., J. M. Riggs, S. Gilfillan, M. Bugatti, W. Vermi, R. Kolbeck, E. R. Unanue, M. A. Sanjuan, and M. Colonna. 2014. Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J. Exp. Med. 211: 1977-1991.
13. Stary, G., C. Bangert, M. Tauber, R. Strohal, T. Kopp, and G. Stingl. 2007. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J. Exp. Med. 204: 1441-1451.
14. Drobits, B., M. Holcmann, N. Amberg, M. Swiecki, R. Grundtner, M. Hammer, M. Colonna, and M. Sibilia. 2012. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J. Clin. Invest. 122: 575-585.
15. Chan, C. W., E. Crafton, H. N. Fan, J. Flook, K. Yoshimura, M. Skarica, D. Brockstedt, T. W. Dubensky, M. F. Stins, L. L. Lanier, et al. 2006. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12: 207-213.
16. Taieb, J., N. Chaput, C. Ménard, L. Apetoh, E. Ullrich, M. Bonmort, M. Péquignot, N. Casares, M. Terme, C. Flament, et al. 2006. A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12: 214-219.
17. + cells identify them as a subset of NK cells. J. Exp. Med. 204: 2561-2568.
18. + interferon-producing killer dendritic cells are activated natural killer cells. J. Exp. Med. 204: 2569-2578.
19. Caminschi, I., F. Ahmet, K. Heger, J. Brady, S. L. Nutt, D. Vremec, S. Pietersz, M. H. Lahoud, L. Schofield, D. S. Hansen, et al. 2007. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J. Exp. Med. 204: 2579-2590.
20. Guimont-Desrochers, F., G. Boucher, Z. Dong, M. Dupuis, A. Veillette, and S. Lesage. 2012. Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation. Blood 119: 4349-4357.
21. Guimont-Desrochers, F., and S. Lesage. 2013. Revisiting the prominent antitumoral potential of pre-mNK cells. Front. Immunol. 4: 446.
22. Christensen, S. R., J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell, and M. J. Shlomchik. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417-428.
23. Berland, R., L. Fernandez, E. Kari, J. H. Han, I. Lomakin, S. Akira, H. H. Wortis, J. F. Kearney, A. A. Ucci, and T. Imanishi-Kari. 2006. Toll-like receptor 7-de-pendent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity 25: 429-440.
24. Lee, P. Y., Y. Kumagai, Y. Li, O. Takeuchi, H. Yoshida, J. Weinstein, E. S. Kellner, D. Nacionales, T. Barker, K. Kelly-Scumpia, et al. 2008. TLR7-dependent and FcgR-independent production of type I interferon in experimental mouse lupus. J. Exp. Med. 205: 2995-3006.
25. Savarese, E., C. Steinberg, R. D. Pawar, W. Reindl, S. Akira, H. J. Anders, and A. Krug. 2008. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum. 58: 1107-1115.
26. + dendritic cells in cross-presentation is not dictated by antigen capture. Proc. Natl. Acad. Sci. USA 103: 10729-10734.
27. Van Gelder, R. N., M. E. von Zastrow, A. Yool, W. C. Dement, J. D. Barchas, and J. H. Eberwine. 1990. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad. Sci. USA 87: 1663-1667.
28. Team, R. C. 2014. R: A language and environment for statistical computing.
29. Smyth, G. K. 2005. Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor. R. Gentleman, V. Carey, W. Huber, R. Irizarry, and S. Dudoit, eds. Springer, New York, p. 397-420.
30. Murphy, E. D., and J. B. Roths. 1979. Ay chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 22: 1188-1194.
31. Kim, S., K. Iizuka, H. S. Kang, A. Dokun, A. R. French, S. Greco, and W. M. Yokoyama. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3: 523-528.
32. Di Santo, J. P. 2006. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24: 257-286.
33. Waldmann, T. A., and Y. Tagaya. 1999. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17: 19-49.
34. Pletneva, M., H. Fan, J. J. Park, V. Radojcic, C. Jie, Y. Yu, C. Chan, A. Redwood, D. Pardoll, and F. Housseau. 2009. IFN-producing killer dendritic cells are antigen-presenting cells endowed with T-cell cross-priming capacity. Cancer Res. 69: 6607-6614.
35. Wang, K. S., J. Ritz, and D. A. Frank. 1999. IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells. J. Immunol. 162: 299-304.
36. Bezman, N. A., T. Chakraborty, T. Bender, and L. L. Lanier. 2011. miR-150 regulates the development of NK and iNKT cells. J. Exp. Med. 208: 2717-2731.
37. Cichocki, F., M. Felices, V. McCullar, S. R. Presnell, A. Al-Attar, C. T. Lutz, and J. S. Miller. 2011. Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling. J. Immunol. 187: 6171-6175.
38. Xiao, C., D. P. Calado, G. Galler, T. H. Thai, H. C. Patterson, J. Wang, N. Rajewsky, T. P. Bender, and K. Rajewsky. 2007. miR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
39. Huang, V., R. F. Place, V. Portnoy, J. Wang, Z. Qi, Z. Jia, A. Yu, M. Shuman, J. Yu, and L. C. Li. 2012. Upregulation of cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res. 40: 1695-1707.
40. Martin, J., R. H. Jenkins, R. Bennagi, A. Krupa, A. O. Phillips, T. Bowen, and D. J. Fraser. 2011. Post-transcriptional regulation of transforming growth factor β-1 by microRNA-744. PLoS ONE 6: e25044.
41. Li, Q. J., J. Chau, P. J. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Skare, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
42. Bueno, M. J., M. Gómez de Cedrón, U. Laresgoiti, J. Fernández-Piqueras, A. M. Zubiaga, and M. Malumbres. 2010. Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling. Mol. Cell. Biol. 30: 2983-2995.
43. Karin, M., and A. Lin. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3: 221-227.
44. Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 26: 3699-3708.
45. Walzer, T., and E. Vivier. 2006. NK cell development: gas matters. Nat. Immunol. 7: 702-704.
46. Gordon, S. M., J. Chaix, L. J. Rupp, J. Wu, S. Madera, J. C. Sun, T. Lindsten, and S. L. Reiner. 2012. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36: 55-67.
47. Gascoyne, D. M., E. Long, H. Veiga-Fernandes, J. de Boer, O. Williams, B. Seddon, M. Coles, D. Kioussis, and H. J. Brady. 2009. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 10: 1118-1124.
48. Tian, Z., M. E. Gershwin, and C. Zhang. 2012. Regulatory NK cells in autoimmune disease. J. Autoimmun. 39: 206-215.
49. Yabuhara, A., F. C. Yang, T. Nakazawa, Y. Iwasaki, T. Mori, K. Koike, H. Kawai, and A. Komiyama. 1996. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J. Rheumatol. 23: 171-177.
50. Erkeller-Yuksel, F. M., P. M. Lydyard, and D. A. Isenberg. 1997. Lack of NK cells in lupus patients with renal involvement. Lupus 6: 708-712.
51. Park, Y. W., S. J. Kee, Y. N. Cho, E. H. Lee, H. Y. Lee, E. M. Kim, M. H. Shin, J. J. Park, T. J. Kim, S. S. Lee, et al. 2009. Impaired differentiation and cyto-toxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum. 60: 1753-1763.
52. Schepis, D., I. Gunnarsson, M. L. Eloranta, J. Lampa, S. H. Jacobson, K. Kärre, and L. Berg. 2009. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology 126: 140-146.